Heart Transplants Equipment For Medical Specialties
-
Manufactured by Destiny Pharma plcbased in UNITED KINGDOM
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
-
based in USA
QTORINTM rapamycin 3.9% is a novel topical therapy being studied for Pachyonychia Congenita (PC). We are currently enrolling our phase 3 study in ...
-
by XELTIS BVbased in NETHERLANDS
Endogenous Tissue Restoration (ETR) is a new therapeutic approach, enabling the patient’s own body to naturally restore a new blood vessel or heart valve. With ETR, the patient’s natural healing system develops tissue that pervades Xeltis’ device, forming a new, natural and fully functional blood vessel or heart valve within it. As ETR occurs, Xeltis implants are gradually ...
-
Manufactured by Artivion, Incbased in USA
Homografts, such as CryoValve Aortic Valves, are recommended by the current STS Clinical Practice Guidelines3 for patients with extensive active endocarditis destruction of the aortic annulus (Class I, Level of Evidence B) and can be considered for patients with endocarditis without annular destruction, especially when the potential for reinfection is elevated. (Class IIa, Level of evidence ...
-
Manufactured by Shockwave Medical Inc.based in USA
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve regurgitation. Millions of patients worldwide with coronary artery disease who are not candidates for revascularization suffer from refractory angina ...
-
Manufactured by CellProtherabased in FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...
-
Manufactured by Palisade Biobased in USA
Our lead asset LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. The therapy is being developed for administration prior to major surgeries that are at risk of disrupting the intestinal epithelial ...
-
Manufactured by Uscom Ltdbased in AUSTRALIA
USCOM 1A uses advanced Doppler hemodynamics to monitor cardiac blood flow. Stroke Volume (SV) monitoring changes the way we manage fluid, inotropes, and vaso-actives, and how we diagnose and manage sepsis, heart failure and ...
-
Manufactured by SynCardia Systems, LLC,based in USA
The SynCardia 70cc temporary Total Artificial Heart (TAH) is the world’s first and only commercially approved total heart replacement. With more than 1,700 implants worldwide, the 70cc TAH accounts for more than 600 patient-years of ...
-
Manufactured by P+F Products + Features GMBHbased in AUSTRIA
The Vienna Aortic Self-Expandable Transcatheter Valve is designed to treat severe aortic stenosis in patients at medium to high risk for open heart surgery. The minimally invasive heart valve replaces the native valve without the need for concomitant surgical removal and is placed throught femoral access. The new generation device comes fully premounted with specially prepared bovine pericardium, ...
-
Manufactured by W.O.M. World of Medicine GmbHbased in GERMANY
In Minimally Invasive Medicine, good visibility and precise incisions are the nuts and bolts. However, both are only possible when there is enough space for the scope and medical instruments. Insufflators and Pumps are needed to dilate body cavities reliably with medical CO2 or fluid for stable internal surgical sites. WOM is the global leader and pioneer for Insufflators in the field of ...
-
Manufactured by Tonix Pharmaceuticals Holding Corp.based in USA
TNX-1500 is a humanized monoclonal antibody (mAb) directed against CD40-ligand, which is also known as CD154, T-BAM, 5c8 antigen, TRAP and gp39. TNX-1500 incorporates the antigen binding fragment (Fab) region of hu5c8 (recombinant monoclonal antibody to CD40-ligand), that has been extensively characterized at the molecular level in complex with the CD40-ligand. TNX-1500 is being studied and ...
-
Manufactured by BlueRock Therapeuticsbased in USA
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. Those who have suffered a heart ...
-
based in GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
-
Manufactured by Ancora Heart, Incbased in USA
As the only completely transcatheter therapy to treat the enlarged left ventricle, the AccuCinch Ventricular Restoration System is a fundamentally different and innovative device-based therapy designed to improve the structure and function of the heart. For heart failure patients with reduced ejection fraction (HFrEF) who remain symptomatic despite guideline-directed medical therapy, early ...
-
Manufactured by Second Heart Assist, Inc.based in USA
Second Heart Assist objectives are to improve the quality of life by reducing the heart’s work-load and improve perfusion. The enhancement of renal function reduces risks associated with toxic contrasts used in percutaneous catheterization interventions (High Risk PCI). Additionally, the product helps patients recover from cardiogenic shock and get acute decompensating heart failure ...
-
Manufactured by Mölnlycke Health Care ABbased in SWEDEN
All-in-one and split-sheet solutions for a wide variety of procedures. BARRIER® drapes for cardiovascular surgery offer effective fluid control for a dry working area. Our range includes single drapes and sets developed for cardiothoracic surgery, including heart valve replacements, pacemaker surgery, thoracotomy and coronary artery bypass grafting. Made from an impermeable material, BARRIER ...
-
Manufactured by Atrion Medicalbased in USA
Atrion’s QL® Inflation Devices are perfect for a broad range of applications such as balloon catheterization, stent deployment and fluid delivery. ...
-
Manufactured by Abiomedbased in USA
The Impella RP heart pump provides temporary, circulatory support for patients who develop right heart failure. It is the only FDA-approved heart pump indicated for patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infraction, heart transplant or open-heart ...
-
Manufactured by CytoSorbents Corporationbased in USA
he CytoSorb therapy* is based on an extracorporeal blood purification procedure that was shown to effectively reduce excessive levels of inflammatory mediators (see “The Adsorber”). This is intended to alleviate the excess systemic inflammatory response (“cytokine storm”) associated with systemic hyperinflammation or septic shock. Thus, the life-threatening complications ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you